Skip to content

Soothing Gan and Invigorating Pi acupuncture treatment for irritable bowel syndrome: a multicenter randomised controlled trial.

Soothing Gan and Invigorating Pi acupuncture treatment for irritable bowel syndrome: study protocol for a multicenter randomised controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006259
Enrollment
Unknown
Registered
2015-04-14
Start date
2015-04-18
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

the experimental group (Soothing Gan and Invigorating Pi acupuncture group):Soothing Gan and Invigorating Pi acupuncture
control group (western medicine group):western medicine

Sponsors

Jiangsu Provincial Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. comply with IBS-C, IBS-D Rome III diagnostic criteria; 2. aged 18-70 years old; 3. The duration of more than six months or more; 4. the lack of morphological changes and biochemical abnormalities could explain the symptoms; 5. baseline IBS-SSS integral >=75 points; 6. before entering the treatment, at least 2 weeks have not used any drugs for IBS (except for emergency treatment). Nearly three months without receiving acupuncture treatment for IBS, and did not participate in other ongoing clinical researches; 7. signed informed consent, voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: 1. comply with IBS-M, IBS-U Rome III diagnostic criteria; 2. intestinal organic disease, or systemic diseases affect the digestive power (such as gallbladder pancreatitis, hyperthyroidism, diabetes, chronic renal failure, nervous system diseases); 3. associated with the cardiovascular system, liver, kidney, hematopoietic system, mental disorders, cognitive disorders and other serious primary disease; 4. history of abdominal or anorectal surgery; 5. often take drugs or preparations which affect gastrointestinal motility or alter intestinal function; 6. under the age of 18 or over 70 years old; 7. pregnancy, lactation, postpartum <=12 months and allergies; 8. while using other treatments or take other medications, which affect the efficacy or safety for judgments; 9. the patients into the group refuse to be observed or have other destabilizing factors, for example: Failing to comply with the provision,while taking other drugs affect the efficacy and can not judge the efficacy or having incomplete information, etc; 10. installed a pacemaker, metal allergy or severe fear of needles; 11. The involvement of other experiments.

Design outcomes

Primary

MeasureTime frame
Irritable Bowel Syndrome - severity scoring system;

Secondary

MeasureTime frame
Irritable Bowel Syndrome Quality of Life;the correlation of IBS gene subtypes and efficacy;

Countries

China

Contacts

Public ContactJianhua Sun

Jiangsu Provincial Traditional Chinese Medicine Hospital

377201634@qq.com+86 13914722816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026